Compare $AURA vs $MDXG | Chartloom

Compare

$AURA vs $MDXG

Aura Biosciences Inc · MiMedx Group Inc

AURA

Aura Biosciences Inc

MDXG

MiMedx Group Inc

Compare $AURA vs $MDXG

Comparing Aura Biosciences Inc and MiMedx Group Inc

AURAAura Biosciences Inc

MDXGMiMedx Group Inc

AURAAura Biosciences Inc

Market cap

$676M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

23.4%

52W performance

7.4%

FCF yield

-15.3%

MDXGMiMedx Group Inc

Market cap

$681M

P/E (TTM)

110.63x

Forward P/E (NTM)

130.81x

Forward P/S (NTM)

2.16x

Rev growth (TTM)

-2.4%

YTD performance

-27.9%

52W performance

-34.2%

FCF yield

6.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AURA

MDXG

Detailed metrics comparison

AURA

Aura Biosciences Inc

MDXG

MiMedx Group Inc

Market Cap

AURA$676M

MDXG$681M

Enterprise Value

AURA$609M

MDXG$562M

Price

AURA$6.54

MDXG$4.67

P/E Ratio

AURAN/A

MDXG110.63x

P/S Ratio

AURA0.00x

MDXG1.92x

EV/Sales

AURA0.00x

MDXG1.58x

EV/EBITDA

AURA0.00x

MDXG27.54x

P/B Ratio

AURA2.00x

MDXG3.10x

P/FCF Ratio

AURAN/A

MDXG15.32x

EV/FCF

AURA-5.89x

MDXG12.65x

PEG Ratio

AURAN/A

MDXGN/A

Forward P/E (NTM)

AURAN/A

MDXG130.81x

Forward P/S (NTM)

AURAN/A

MDXG2.16x

Revenue (TTM)

AURA$0

MDXG$355M

Revenue Growth (YoY)

AURAN/A

MDXG-2.4%

Forward Rev Growth

AURA591.6%

MDXG22.1%

Gross Margin (TTM)

AURA0.0%

MDXG78.8%

Operating Margin (TTM)

AURA0.0%

MDXG2.5%

EBITDA Margin (TTM)

AURA0.0%

MDXG5.7%

Net Margin (TTM)

AURA0.0%

MDXG1.8%

FCF Margin (TTM)

AURAN/A

MDXG12.5%

Net Income (TTM)

AURA$-131M

MDXG$6M

FCF (TTM)

AURA$-103M

MDXG$44M

EPS (TTM)

AURA-$1.38

MDXG$0.04

ROE (TTM)

AURA-7318.0%

MDXG2.6%

ROA (TTM)

AURA-6200.0%

MDXG2.0%

ROIC (TTM)

AURA-7318.0%

MDXG2.4%

Cash

AURA$68M

MDXG$136M

Debt

AURA$0

MDXG$17M

Net Cash/Debt

AURA$68M

MDXG$119M

Current Ratio (TTM)

AURA16.82x

MDXG5.33x

Quick Ratio (TTM)

AURA16.69x

MDXG4.79x

Debt/Equity (TTM)

AURA0.00x

MDXG0.08x

Debt/Assets (TTM)

AURA0.0%

MDXG0.0%

Interest Coverage (TTM)

AURAN/A

MDXGN/A

Net Debt/EBITDA (TTM)

AURA0.00x

MDXG0.00x

Beta

AURA0.45

MDXG1.20

52W Performance

AURA7.4%

MDXG-34.2%

YTD Performance

AURA23.4%

MDXG-27.9%

% from 52W High

AURA-31.4%

MDXG-41.4%

% from 52W Low

AURA38.3%

MDXG54.1%

Asset Turnover (TTM)

AURA0.00x

MDXG1.14x

FCF Yield (TTM)

AURA-15.3%

MDXG6.5%

Earnings Yield (TTM)

AURA-19.4%

MDXG0.9%

Dividend Yield (TTM)

AURAN/A

MDXGN/A

Rule of 40

AURA0.0

MDXG10.1

EV/GP/RG

AURAN/A

MDXG0.09

Ticker research

View AURA research View MDXG research

Metric	AURA Aura Biosciences Inc	MDXG MiMedx Group Inc
Market & Valuation
Market Cap	$676M	$681M
Enterprise Value	$609M	$562M
Price	$6.54	$4.67
P/E Ratio	N/A	110.63x
P/S Ratio	0.00x	1.92x
EV/Sales	0.00x	1.58x
EV/EBITDA	0.00x	27.54x
P/B Ratio	2.00x	3.10x
P/FCF Ratio	N/A	15.32x
EV/FCF	-5.89x	12.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	130.81x
Forward P/S (NTM)	N/A	2.16x
Revenue & Growth
Revenue (TTM)	$0	$355M
Revenue Growth (YoY)	N/A	-2.4%
Forward Rev Growth	591.6%	22.1%
Profitability
Gross Margin (TTM)	0.0%	78.8%
Operating Margin (TTM)	0.0%	2.5%
EBITDA Margin (TTM)	0.0%	5.7%
Net Margin (TTM)	0.0%	1.8%
FCF Margin (TTM)	N/A	12.5%
Net Income (TTM)	$-131M	$6M
FCF (TTM)	$-103M	$44M
EPS (TTM)	-$1.38	$0.04
ROE (TTM)	-7318.0%	2.6%
ROA (TTM)	-6200.0%	2.0%
ROIC (TTM)	-7318.0%	2.4%
Financial Health
Cash	$68M	$136M
Debt	$0	$17M
Net Cash/Debt	$68M	$119M
Current Ratio (TTM)	16.82x	5.33x
Quick Ratio (TTM)	16.69x	4.79x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.45	1.20
52W Performance	7.4%	-34.2%
YTD Performance	23.4%	-27.9%
% from 52W High	-31.4%	-41.4%
% from 52W Low	38.3%	54.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.14x
FCF Yield (TTM)	-15.3%	6.5%
Earnings Yield (TTM)	-19.4%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	10.1
EV/GP/RG	N/A	0.09
Ticker research	View AURA research	View MDXG research

Valuation

P/E Ratio

MDXG

110.63x

P/S Ratio

AURA

0.00x

MDXG

1.92x

EV/FCF

AURA

-5.89x

MDXG

12.65x

Growth & revenue

Revenue Growth TTM

MDXG

-2.4%

Forward Revenue Growth

AURA

591.6%

MDXG

22.1%

Profitability & performance

Gross Margin

MDXG

78.8%

AURA

0.0%

ROE

MDXG

2.6%

AURA

-7318.0%

FCF Yield %

MDXG

6.5%

AURA

-15.3%

52-Week Performance

AURA

7.4%

MDXG

-34.2%

Detailed metrics comparison

AURA

Aura Biosciences Inc

MDXG

MiMedx Group Inc

Market Cap

AURA$676M

MDXG$681M

Enterprise Value

AURA$609M

MDXG$562M

Price

AURA$6.54

MDXG$4.67

P/E Ratio

AURAN/A

MDXG110.63x

P/S Ratio

AURA0.00x

MDXG1.92x

EV/Sales

AURA0.00x

MDXG1.58x

EV/EBITDA

AURA0.00x

MDXG27.54x

P/B Ratio

AURA2.00x

MDXG3.10x

P/FCF Ratio

AURAN/A

MDXG15.32x

EV/FCF

AURA-5.89x

MDXG12.65x

PEG Ratio

AURAN/A

MDXGN/A

Forward P/E (NTM)

AURAN/A

MDXG130.81x

Forward P/S (NTM)

AURAN/A

MDXG2.16x

Revenue (TTM)

AURA$0

MDXG$355M

Revenue Growth (YoY)

AURAN/A

MDXG-2.4%

Forward Rev Growth

AURA591.6%

MDXG22.1%

Gross Margin (TTM)

AURA0.0%

MDXG78.8%

Operating Margin (TTM)

AURA0.0%

MDXG2.5%

EBITDA Margin (TTM)

AURA0.0%

MDXG5.7%

Net Margin (TTM)

AURA0.0%

MDXG1.8%

FCF Margin (TTM)

AURAN/A

MDXG12.5%

Net Income (TTM)

AURA$-131M

MDXG$6M

FCF (TTM)

AURA$-103M

MDXG$44M

EPS (TTM)

AURA-$1.38

MDXG$0.04

ROE (TTM)

AURA-7318.0%

MDXG2.6%

ROA (TTM)

AURA-6200.0%

MDXG2.0%

ROIC (TTM)

AURA-7318.0%

MDXG2.4%

Cash

AURA$68M

MDXG$136M

Debt

AURA$0

MDXG$17M

Net Cash/Debt

AURA$68M

MDXG$119M

Current Ratio (TTM)

AURA16.82x

MDXG5.33x

Quick Ratio (TTM)

AURA16.69x

MDXG4.79x

Debt/Equity (TTM)

AURA0.00x

MDXG0.08x

Debt/Assets (TTM)

AURA0.0%

MDXG0.0%

Interest Coverage (TTM)

AURAN/A

MDXGN/A

Net Debt/EBITDA (TTM)

AURA0.00x

MDXG0.00x

Beta

AURA0.45

MDXG1.20

52W Performance

AURA7.4%

MDXG-34.2%

YTD Performance

AURA23.4%

MDXG-27.9%

% from 52W High

AURA-31.4%

MDXG-41.4%

% from 52W Low

AURA38.3%

MDXG54.1%

Asset Turnover (TTM)

AURA0.00x

MDXG1.14x

FCF Yield (TTM)

AURA-15.3%

MDXG6.5%

Earnings Yield (TTM)

AURA-19.4%

MDXG0.9%

Dividend Yield (TTM)

AURAN/A

MDXGN/A

Rule of 40

AURA0.0

MDXG10.1

EV/GP/RG

AURAN/A

MDXG0.09

Ticker research

View AURA research View MDXG research

Metric	AURA Aura Biosciences Inc	MDXG MiMedx Group Inc
Market & Valuation
Market Cap	$676M	$681M
Enterprise Value	$609M	$562M
Price	$6.54	$4.67
P/E Ratio	N/A	110.63x
P/S Ratio	0.00x	1.92x
EV/Sales	0.00x	1.58x
EV/EBITDA	0.00x	27.54x
P/B Ratio	2.00x	3.10x
P/FCF Ratio	N/A	15.32x
EV/FCF	-5.89x	12.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	130.81x
Forward P/S (NTM)	N/A	2.16x
Revenue & Growth
Revenue (TTM)	$0	$355M
Revenue Growth (YoY)	N/A	-2.4%
Forward Rev Growth	591.6%	22.1%
Profitability
Gross Margin (TTM)	0.0%	78.8%
Operating Margin (TTM)	0.0%	2.5%
EBITDA Margin (TTM)	0.0%	5.7%
Net Margin (TTM)	0.0%	1.8%
FCF Margin (TTM)	N/A	12.5%
Net Income (TTM)	$-131M	$6M
FCF (TTM)	$-103M	$44M
EPS (TTM)	-$1.38	$0.04
ROE (TTM)	-7318.0%	2.6%
ROA (TTM)	-6200.0%	2.0%
ROIC (TTM)	-7318.0%	2.4%
Financial Health
Cash	$68M	$136M
Debt	$0	$17M
Net Cash/Debt	$68M	$119M
Current Ratio (TTM)	16.82x	5.33x
Quick Ratio (TTM)	16.69x	4.79x
Debt/Equity (TTM)	0.00x	0.08x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.45	1.20
52W Performance	7.4%	-34.2%
YTD Performance	23.4%	-27.9%
% from 52W High	-31.4%	-41.4%
% from 52W Low	38.3%	54.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	1.14x
FCF Yield (TTM)	-15.3%	6.5%
Earnings Yield (TTM)	-19.4%	0.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	10.1
EV/GP/RG	N/A	0.09
Ticker research	View AURA research	View MDXG research